Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-06-01FDA Approved: NOVOLIN 70/30 — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for Novo Nordisk's Novolin 70/30 (human insulin), updating the product's regulatory status.
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone [Phase 3]
A Phase 3 study compared saxagliptin co-administered with dapagliflozin and metformin to sitagliptin with metformin in adults with Type 2 di…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Mineralocorticoid Receptor Antagonists in Type 2 Diabetes [Phase 4]
Phase 4 clinical trial update indicates completion of a study evaluating mineralocorticoid receptor antagonists in Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Safety and Efficacy Study of Albiglutide Liquid Drug Product in Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial update for albiglutide liquid product in type 2 diabetes shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use [NA]
The study evaluates the Enlite glucose sensor for up to 144 hours (6 days) of continuous use in people with type 1 diabetes and type 2 diabe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating curcumin's effects on NFE2L2 gene expression, antioxidant capacity, and renal function in diabe…
-
CLINICAL_TRIALS trial_result · 2018-05-29Clinical Trial Update: Comparing Efficacy and Safety of Thrice Daily Versus Twice Daily NovoMix® 30 (Biphasic Insulin Aspart 30) in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin [Phase 4]
Phase 4 trial comparing thrice-daily versus twice-daily NovoMix 30 in type 2 diabetes patients inadequately controlled with basal insulin; r…
-
FDA approval · 2018-05-25FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Does Time Restricted Feeding Improve Glycaemic Control in Overweight Men? [NA]
A University of Adelaide–sponsored clinical trial assessing whether time-restricted feeding improves glycemic control in overweight men with…
-
CLINICAL_TRIALS trial_result · 2018-05-24Clinical Trial Update: Intervention Study - Effectiveness of Smartphone Delivered Interval Walking Training to Patients With Type 2 Diabetes [NA]
A completed clinical trial evaluated the effectiveness of a smartphone-delivered interval walking training program for adults with Type 2 di…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects [Phase 4]
Phase 4 exploratory trial comparing repeat dosing of albiglutide to exenatide on gastric myoelectrical activity and gastric emptying in adul…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Community Health Worker Diabetes Prevention Intervention [NA]
This update notes completion of a community health worker–led diabetes prevention trial.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Efficacy Study of Liraglutide vs.Sitagliptin vs. Glargine on Liver Fat in T2DM Subjects [Phase 4]
Phase 4 efficacy trial comparing liraglutide, sitagliptin, and insulin glargine for liver fat in adults with type 2 diabetes mellitus and no…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Use of Sitagliptin for Stress Hyperglycemia or Mild Diabetes Following Cardiac Surgery [Phase 4]
Phase 4 trial evaluating sitagliptin for stress hyperglycemia or mild diabetes after cardiac surgery was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Early Changes of Diabetes Parameters After Obesity Therapy [NA]
This trial update reports early changes in diabetes parameters following obesity therapy in bariatric surgery candidates, sponsored by the U…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Impact of Rutin and Vitamin C Combination on Oxidative Stress, Insulin Sensitivity and Lipid Profile in Type 2 Diabetic Patients [Phase 2, Phase 3]
Phase 2/3 trial evaluating the effects of a rutin and vitamin C combination on oxidative stress, insulin sensitivity, and lipid profile in T…
-
CLINICAL_TRIALS trial_result · 2018-05-16Clinical Trial Update: Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 Diabetes
This clinical trial update describes using the FibroTouch device to screen for advanced liver fibrosis in patients with nonalcoholic fatty l…
-
CLINICAL_TRIALS withdrawal · 2018-05-16Clinical Trial Update: Glucotoxicity and Acute Exercise [NA]
The clinical trial NCT01771614 on glucotoxicity and acute exercise in individuals with diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy [Phase 2]
Phase 2 trial results evaluate safety and efficacy of S-707106 in adults with type 2 diabetes mellitus not adequately controlled by metformi…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium Function [Phase 3]
Phase 3 trial evaluating empagliflozin effects on macrovascular and microvascular circulation and endothelial function in adults with type 2…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Dietary Fiber and Cardiovascular Inflammatory Markers
This completed clinical trial evaluated the effect of dietary fiber on cardiovascular inflammatory markers.
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment [Phase 1]
This Phase 1 study evaluated the pharmacokinetics, safety and tolerability of oral semaglutide in subjects with hepatic impairment to assess…
-
EMA approval · 2018-05-14EMA Authorised: Prandin (repaglinide) — Novo Nordisk A/S
The EMA has authorised Prandin (repaglinide) for Type 2 diabetes, with Novo Nordisk A/S as the marketing authorisation holder.
-
CLINICAL_TRIALS research · 2018-05-14Clinical Trial Update: The Vitamin B Status in Type 2 Diabetes (VITA) Study
The Vitamin B Status in Type 2 Diabetes (VITA) study updates the status of research on vitamin B status in adults with type 2 diabetes, incl…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Effect of Dapagliflozin on Microvascular and Macrovascular Circulation and Total Body Sodium Content [Phase 3]
A Phase 3 trial evaluating the effects of dapagliflozin on microvascular and macrovascular circulation and total body sodium content in adul…